Radiomic Response Evaluation Of Recurrent Or Metastatic Head And Neck Squamous Cell Cancer (R/M Hnscc) Patients Receiving Pembrolizumab On Keynote-012 Study.
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2020)